AstraZeneca's Phase I / II Covid-19 vaccine trial unlikely to report convincing protection data

Press/Media: Research

PeriodAug 27 2020

Media coverage

1

Media coverage

  • TitleAstraZeneca's Phase I / II Covid-19 vaccine trial unlikely to report convincing protection data
    Media name/outletMarketLine NewsWire (Formerly Datamonitor)
    Country/TerritoryUnited Kingdom
    Date27/8/20
    PersonsIra Longini
View all 1
View less